Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months | NEJM

Original Article from The New England Journal of Medicine — Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months